Plain-English translation of NCT06092125 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This is a large research study that uses a special type of brain imaging called PET/MR to help doctors diagnose and understand four serious neurological conditions: Alzheimer's disease, Parkinson's disease, epilepsy, and malignant brain tumors. The study aims to identify specific imaging patterns that can help doctors recognize these conditions earlier and predict how they might progress in individual patients. Researchers will collect detailed imaging data from over 2,000 patients and healthy volunteers to develop better diagnostic tools.
Current methods for diagnosing these brain conditions can be slow and uncertain, which delays treatment and care. By studying advanced imaging scans, researchers hope to find clearer, more reliable patterns that will help doctors recognize these diseases faster and predict which patients are at highest risk of developing serious symptoms.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would come to Xuanwu Hospital in Beijing for an advanced brain imaging scan called PET/MR, which combines two types of imaging to give detailed pictures of your brain's structure, blood flow, function, and chemical activity. The study may also involve follow-up visits over time so researchers can track how your condition changes. You may also be asked to answer questions about your health and symptoms. The exact number of visits and imaging scans would depend on which condition you have and your individual circumstances.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Xuanwu Hospital, Beijing
Collaborators
Peking University Cancer Hospital & Institute, Shanghai Zhongshan Hospital
Enrollment target
~2,300 participants
Started
October 2022
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jie Lu, Phd
Xuanwu Hospital of Capital Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.